KNG1 Antikörper (AA 138-166)
Kurzübersicht für KNG1 Antikörper (AA 138-166) (ABIN7870583)
Target
Alle KNG1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 138-166
-
Verwendungszweck
- KNG1 Antibody / Kininogen 1 / Bradykinin
-
Aufreinigung
- Antigen affinity purified
-
Immunogen
- A portion of amino acids 138-166 from the human protein was used as the immunogen for the KNG1 antibody.
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- The stated application concentrations are suggested starting points. Titration of the KNG1 antibody may be required due to differences in protocols and secondary/substrate sensitivity.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot the KNG1 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- KNG1 (Kininogen 1 (KNG1))
-
Andere Bezeichnung
- KNG1
-
Hintergrund
- This gene uses alternative splicing to generate two different proteins- high molecular weight kininogen (HMWK) and low molecular weight kininogen (LMWK). HMWK is essential for blood coagulation and assembly of the kallikrein-kinin system. Also, bradykinin, a peptide causing numerous physiological effects, is released from HMWK. In contrast to HMWK, LMWK is not involved in blood coagulation. Three transcript variants encoding different isoforms have been found for this gene.
-
UniProt
- P01042
-
Pathways
- ACE Inhibitor Pathway, Glycosaminoglycan Metabolic Process
Target
-